Results 81 to 90 of about 62,852 (172)

The need for a pneumococcal vaccine [PDF]

Journal of Antimicrobial Chemotherapy, 1980
openaire   +2 more sources

Factors Associated with Influenza and Pneumococcal Vaccine Hesitancy Among Patients with AECOPD: A Cross-Sectional Study in China Using the 3C Model. [PDF]

Int J Chron Obstruct Pulmon Dis
Xin Y, He R, Ren X, Yang T, Wang Y, Su X.   +5 more
europepmc   +1 more source

Is it time to administer the pneumococcal vaccine to healthy unvaccinated children older than 5 years of age? [PDF]

J Res Med Sci
Sayyahfar S.
europepmc   +1 more source

Pneumococcal carriage prevalence, serotype distribution, and vaccine coverage in Ethiopia 12 years after pneumococcal vaccine introduction. [PDF]

Vaccine
Bizuayehu HY, Kebede Y, Deressa M, Solomon E, Marami D, Karani A, Gardiner E, Dessie Y, Scott JAG, Gallagher KE.   +9 more
europepmc   +1 more source

Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial. [PDF]

Hum Vaccin Immunother
Giriappa B, Choraria N, Ponce P, Drozd J, Su X, Lei L, Portka M, Pai S, Anderson A, Bickham K, Watson W, McElwee K.   +11 more
europepmc   +1 more source

Pneumococcal vaccines and pneumonias [PDF]

Jornal de Pediatria, 2012
openaire   +2 more sources

Changes and determinants of pneumococcal vaccine uptake in Ethiopia. [PDF]

PLOS Glob Public Health
Mamo BT, Geram FG, Getnet KY, Bonger ZT.
europepmc   +1 more source

Factors associated with willingness to accept pneumococcal vaccine based on the Health Belief Model among the elderly (≥60 years) living in Klang Valley, Malaysia. [PDF]

Hum Vaccin Immunother
Mohd Hisham MF, Sreeramareddy CT.
europepmc   +1 more source

IAPSM's Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India. [PDF]

Indian J Community Med
Rao CR, Kamath VG, Nadda A, Parida SP, Sharma N, Goel K, Shetty RS, Verma M, Singh AK, Mishra A, Kiran S, Sankhe L, Gupta M.   +12 more
europepmc   +1 more source

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8. [PDF]

Clin Infect Dis
Scott PT, Pathirana J, Kato A, Tytus R, Perez CM, Gilchrist NL, Kanou H, Ha Yoo K, Kania G, Nissen M, Russell AF, Fernsler D, Waleed M, Li J, Buchwald UK, Platt HL.   +15 more
europepmc   +1 more source